[1]Sidaway P.Diabetic nephropathy:Heparanase mediates renal injury[J].Nat Rev Nephrol,2014, 10(9):483.
[2]FernandezFernandez B,Ortiz A,GomezGuerrero C,et al.Therapeutic approaches to diabetic nephropathy beyond the RAS[J].Nat Rev Nephrol, 2014,10(6):325-346.
[3]Qiu YY,Tang LQ.Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy[J].Pharmacol Res,20l6,114:251-264.
[4]ArellanoBuendla AS,GarciaArroyo FE,CristobalGarcia M,et al.Urinary excretion of neutrophil gelatinaseassociated lipocalin in diabetic rats[J].Oxid Med Cell Longev,2014,2014:961326.
[5]ArellanoBuendla AS,TostadoGonzalez M,GarciaArroyo FE,et al.Antiinflammatory therapy modulates Nrf2Keapl in kidney from rats with diabetes[J].Oxid Med Cell Longev,2016,2016:4693801.
[6]胡雅国,张利棕,邓九零,等.氧化应激在血糖波动加速GK大鼠糖尿病肾病发病过程中的作用[J].中国糖尿病杂志,2015,23(12):1106-1110.
[7]Ha H,Hwang IA,Park JH,et al.Role of reactive oxygen species in the pathogenesis of diabetic nephropathy[J].Diabetes Res Clin Pract,2008, 82(Suppl 1):S42-45.
[8]Sakai N,Wada T,Furuichi K,et al.Involvement of extracellular signalregulated kinase and p38 in human diabetic nephropathy[J].Am J Kidney Dis,2005,45(1):54-65.
[9]Sedeek M,Callera G,Montezano A,et al.Critical role of Nox4based NADPH oxidase in glucoseinduced oxidative stress in the kidney: implications in type 2 diabetic nephropathy[J].Am J Physiol Renal Physiol, 2010,299(6):F1348-1358.
[10]Chakraborty A,Chowdhury S,Bhattacharyya M.Effect of metformin on oxidative stress,nitrosative stress and inflammatory biomarkers in type 2 diabetes patients[J].Diabetes Res Clin Pract,2011,93(1):56-62.
[11]Esteghamati A,Eskandari D,Mirmiranpour H,et al.Effects of metformin on markers of oxidative stress and antioxidant reserve in patients with newly diagnosed type 2 diabetes:A randomized clinical trial[J]. Clin Nutr,2013,32(2):179-185.
[12]Abdulkadir AA,Thanoon IA.Comparative effects of glibenclamide and metformin on C-Reactive protein and oxidant/antioxidant status in patients with Type II diabetes mellitus[J].Sultan Qaboos Univ Med J,2012,12(1):55-61.
[13]Marks DC,Belov L,Davey MW,et al.The MTT cell viability assay for cytotoxicity testing in multidrugresistant human leukemic cells[J].Leuk Res,1992,16(12):11651173.
[14]Schmittgen TD,Livak KJ.Analyzing realtime PCR data by the comparative C(T) method[J].Nat Protoc,2008,3(6):1101-1108.
[15]Panigrahy SK,Bhatt R,Kumar A.Reactive oxygen species:sources,consequences and targeted therapy in type 2 diabetes[J].J Drug Target,2017,25(2):93-101.
[16]Korashy HM,ElKadi AO.The role of aryl hydrocarbon receptor and the reactive oxygen species in the modulation of glutathione transferase by heavy metals in murine hepatoma cell lines[J].Chem Biol Interact,2006, 162(3):237-248.
[17]Barnes JL,Gorin Y.Myofibroblast differentiation during fibrosis:role of NAD (P) H oxidases[J].Kidney Int,2011,79(9):944-956.
[18]Bedard K,Krause KH.The NOX family of ROSgenerating NADPH oxidases:physiology and pathophysiology[J].Physiol Rev,2007,87(1):245-313.
[19]Xia L,Wang H,Goldberg HJ,et al.Mesangial cell NADPH oxidase upregulation in high glucose is protein kinase C dependent and required for collagen IV expression[J].Am J Physiol Renal Physiol,2006,290(2): F345-356 .
[20]Zhang L,Pang S,Deng B,et al.High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/NFkB/NADPH oxidase/ROS pathway, which is inhibited by resveratrol[J].Int J Biochem Cell Biol,2012,44(4):629-638.
[21]Pan HZ,Zhang L,Guo MY,et al.The oxidative stress status in diabetes mellitus and diabetic nephropathy[J].Acta Diabetol,2010,47(Suppl 1):71-76.
[22]Knizhnik AV,Kovaleva OV,Komelkov AV,et al.Arf6 promotes cell proliferation via the PLDmTORC1 and p38MAPK pathways[J].J Cell Biochem 2012,113(1):360371.
[23]Lee YL,Chen CW,Liu FH,et al.Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPKmediated erythroid differentiation[J].PLoS One,2013,8(4):e61939
[24]Nishida M,Tanabe S,Maruyama Y,et al.G alpha 12/13 and reactive oxygen speciesdependent activation of cJun NH2terminal kinase and p38 mitogenactivated protein kinase by angiotensin receptor stimulation in rat neonatal cardiomyocytes[J].J Biol Chem,2005,280(18):18434-18441.
[25]Zarrouki B,Soares AF,Guichardant M,et al.The lipid peroxidation endproduct 4HNE induces COX2 expression through p38MAPK activation in 3T3L1 adipose cell[J].FEBS Lett,2007,581(13):23942400.
[26]Nowak JZ,WiktorowskaOwczarek A.Neovascularization in ocular tissues: mechanisms and role of proangiogenic and antiangiogenic factors[J]. Klin Oczna,2004,106(1/2):90-97.
[27]Song Y,Liu J,Zhang F,et al.Antioxidant effect of quercetin against acute spinal cord injury in rats and its correlation with the p38MAPK/iNOS signaling pathway[J].Life Sci,2013,92(24/26):12151221.
[28]梅艳,欧三桃.二甲双胍对糖尿病大鼠肾脏的保护作用及其机制研究[J].中国现代医学杂志,2017,27(20):1-5.
[29]Zhai L,Gu J,Yang D,et a1.Metformin ameliorates podocyte damage by restoring renal tissue podocalyxin expression in type 2 diabetic rats[J].J Diabetes Res,2015,2015:231825.
[30]Zhai L,Gu J,Yang D, et a1.Metformin ameliorates podocyte damage by restoring renal tissue nephrin expression in type 2 diabetic rats[J].J Diabetes,2017, 9(5):510-517.
[31]余丹,叶山东,李业琼,等.二甲双胍对2型糖尿病模型大鼠肾组织蛋白激酶Cβ表达的影响[J].中国糖尿病杂志,2017,25(10):904-908.
[32]李业琼,叶山东,翟丽敏,等.二甲双胍对2型糖尿病模型大鼠肾组织AGEs表达的影响[J]. 中国药理学通报,2016,32(5):703-707.
[33]李业琼,叶山东,翟丽敏,等.二甲双胍对2型糖尿病模型大鼠TNFα表达的影响[J]. 安徽医科大学学报,2016,51(9):1312-1315.
[34]戴晓康,叶山东.二甲双胍对2型糖尿病患者尿TNFα排泄的影响[J]. 南京医科大学学报(自然科学版),2016,36(6):746-749.
[35]戴晓康,邢燕,叶山东.二甲双胍对2型糖尿病患者尿单核细胞趋化蛋白-1排泄的影响[J]. 中国糖尿病杂志,2016,24(2):123-126.
[36]Ravindran S,Kuruvilla V,Wilbur K,et a1.Nephroprotective effects of metformin in diabetic nephropathy[J].J Cell Physiol,2017,232(4):731-742.
[37]余丹,叶山东.二甲双胍对糖尿病肾病的保护作用及其抗氧化应激机制[J].临床与病理杂志,2017,37(4):862-867.
[38]Dai J,Liu M,Ai Q,et a1.Involvement of catalase in the protective benefits of metformin in mice with oxidative liver injury[J].Chem Biol Interact,2014,216:34-42.
[39]Ishibashi Y,Matsui T,Takeuchi M,et al.Metformin inhibits advanced glycation end products(AGEs)induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression[J].Horm Metab Res,2012,44(12):891-895.
[40]Kim J, Shon E, Kim CS, et al.Renal podocyte injury in a rat model of type 2 diabetes is prevented by metformin[J]. Exp Diabetes Res,2012,2012:210821.
[41]Tseng SC,Huang YC,Chen HJ,et al.Metforminmediated downregulation of p38 mitogenactivated protein kinasedependent excision repair crosscomplementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to paclitaxel[J].Biochem Pharmacol, 2013,85(4):583-594.
[42]Kappe C,Holst JJ,Zhang Q,et al.Molecular mechanisms of lipoapoptosis and metformin protection in GLP-1 secreting cells[J]. Biochem Biophys Res Commun,2012,427(1):91-95.
[43]陈丽莉,范国洽,韩蕊,等.二甲双胍降低2型糖尿病大鼠主动脉磷酸化丝裂原活化蛋白激酶的蛋白表达[J].中国循环杂志,2015,30(5):487-491. |